Corrigendum to molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspective progress in retinal and eye research (2018) Vol 63,107-131

Affiliations

¹ School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil; Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA.
² Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea.
³ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA.
⁴ Pharmaceutical Research and Development, Ezequiel Dias Foundation, Belo Horizonte, Brazil.
⁵ School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
⁶ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA; Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea.
⁷ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA; Department of Chemical Engineering and Materials Sciences, University of California, Irvine, CA, USA; Department of Biomedical Engineering, University of California, Irvine, CA, USA; Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA. Electronic address: kwonyj@uci.edu.

Published Erratum

Marina França Dias et al. Prog Retin Eye Res. 2018 Sep.

. 2018 Sep:66:220-221.

doi: 10.1016/j.preteyeres.2018.08.001. Epub 2018 Aug 11.

¹ School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil; Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA.
² Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea.
³ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA.
⁴ Pharmaceutical Research and Development, Ezequiel Dias Foundation, Belo Horizonte, Brazil.
⁵ School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
⁶ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA; Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, South Korea.
⁷ Department of Pharmaceutical Sciences, University of California, Irvine, CA, USA; Department of Chemical Engineering and Materials Sciences, University of California, Irvine, CA, USA; Department of Biomedical Engineering, University of California, Irvine, CA, USA; Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA. Electronic address: kwonyj@uci.edu.

No abstract available

Erratum for

Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives.
Dias MF, Joo K, Kemp JA, Fialho SL, da Silva Cunha A Jr, Woo SJ, Kwon YJ. Dias MF, et al. Prog Retin Eye Res. 2018 Mar;63:107-131. doi: 10.1016/j.preteyeres.2017.10.004. Epub 2017 Oct 31. Prog Retin Eye Res. 2018. PMID: 29097191 Review.